Exelixis execs win bonuses for first Cometriq approval; TransCelerate taps R&D vet as new CEO;

 @FierceBiotech: Piramal continues market-access blitz with Abacus takeover. Story | Follow @FierceBiotech

@JohnCFierce: Isis gets $30M up front in a new pact with Biogen to develop antisense drugs. $200M per in biobucks. News | Follow @JohnCFierce

 @RyanMFierce: Wow. Amgen buying deCODE for $415M. Wants to validate disease targets for drug development. | Follow @RyanMFierce

> Exelixis ($EXEL) execs will split $234,000 in bonuses following the first approval for their cancer drug Cometriq (cabozantinib). Story

> R&D vet Dalvir Gill was named CEO of TransCelerate, an industry consortium aimed at collaborating on more efficient R&D processes. Release

> Intrexon has made a bid for the remaining shares of Aqua Bounty Technologies. Story (reg. req.)

Pharma News

@FiercePharma: Pay-for-delay to get Supreme Court consideration. News | Follow @FiercePharma

> Bloomberg: SEC looking at InterMune trades by hedge fund. Story

> Eliquis from Pfizer, Bristol-Myers Squibb shows potential for longer use. Report

> FDA panel says no to high-powered painkiller. Article

Medical Device News

 @FierceMedDev: A Finnish company won CE mark status for noninvasive magnetic stimulation to treat major depression. News | Follow @FierceMedDev

@MarkHFierce: GE has clearly wanted Insightec for a long time. The Israeli company uses MRI-guided ultrasound to ablate tissue. Release | Follow @MarkHFierce

 @DamianFierce: Covance says it's the first global CRO to get GLP certification from Chinese regulators. More | Follow @DamianFierce

> Report: Sanofi considering Bayer's glucose-meter unit. Article

> Brain-stimulation antidepression device gets CE marking. Item

> Vela Diagnostics licenses Swift Biosciences' cancer-detection tech. News

Medical Device News

 @FierceMedDev: A Finnish company won CE mark status for noninvasive magnetic stimulation to treat major depression. News | Follow @FierceMedDev

@MarkHFierce: GE has clearly wanted Insightec for a long time. The Israeli company uses MRI-guided ultrasound to ablate tissue. Release | Follow @MarkHFierce

 @DamianFierce: Covance says it's the first global CRO to get GLP certification from Chinese regulators. More | Follow @DamianFierce

> Report: Sanofi considering Bayer's glucose-meter unit. Article

> Brain-stimulation antidepression device gets CE marking. Item

> Vela Diagnostics licenses Swift Biosciences' cancer-detection tech. News

Biotech IT News

> Consortium sifting through MS data to find new endpoint. Report

> Piramal continues market-access blitz with Abacus takeover. News

> Internet advocate slams pharma's social media moves. Story

> Survey: Pharma's social media, mobile use spreads in 2012. Article

CRO News

> Recipharm bets on analytical development with expansion. More

> Covance notches GLP nod from Chinese regulators. Report

> Alimera taps Quintiles to commercialize Iluvien. News

> AMRI re-ups with GE Healthcare, its largest supply partner. Story

And Finally… Investigators backed by DARPA say that in animal studies a new foam technology was able to arrest bleeding, offering a new approach to treating wounded soldiers. Story

 

Suggested Articles

With a new research team, outlook and more than a little help from the tech world, GSK has been quietly going about shoring up its pipeline.

The World Health Organization has called out Big Pharma for its dearth of antibiotic innovation amid a growing threat of antimicrobial resistance.

The trial hit its primary endpoint by the time of an interim analysis, enabling Chi-Med to stop the study and start work on a filing for approval.